Fludarabine oral busulfan: a low toxicity conditioning regimen when plasma level targeting and intravenous busulfan is not available. A brazilian experience (2006)
- Authors:
- USP affiliated authors: SIMOES, BELINDA PINTO - FMRP ; VOLTARELLI, JULIO CESAR - FMRP
- Unidade: FMRP
- Subjects: CÉLULAS-TRONCO (TRANSPLANTE); LEUCEMIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Bone Marrow Transplantation
- ISSN: 0951-3078
- Volume/Número/Paginação/Ano: v. 37, supl. 1, p. S113, res. P532, 2006
- Conference titles: Annual Meeting European Group for Blood and Marrow Transplantation
-
ABNT
SIMÕES, Belinda Pinto et al. Fludarabine oral busulfan: a low toxicity conditioning regimen when plasma level targeting and intravenous busulfan is not available. A brazilian experience. Bone Marrow Transplantation. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 21 maio 2024. , 2006 -
APA
Simões, B. P., Souza, M. P., Mauad, M., Machado, C., Paton, E. J., Pieroni, F., et al. (2006). Fludarabine oral busulfan: a low toxicity conditioning regimen when plasma level targeting and intravenous busulfan is not available. A brazilian experience. Bone Marrow Transplantation. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Simões BP, Souza MP, Mauad M, Machado C, Paton EJ, Pieroni F, Colli G, Zaparolli Y, Stracieri ABPL, Oliveira MC, Moraes D, Voltarelli JC, Colturato VR. Fludarabine oral busulfan: a low toxicity conditioning regimen when plasma level targeting and intravenous busulfan is not available. A brazilian experience. Bone Marrow Transplantation. 2006 ; 37 S113.[citado 2024 maio 21 ] -
Vancouver
Simões BP, Souza MP, Mauad M, Machado C, Paton EJ, Pieroni F, Colli G, Zaparolli Y, Stracieri ABPL, Oliveira MC, Moraes D, Voltarelli JC, Colturato VR. Fludarabine oral busulfan: a low toxicity conditioning regimen when plasma level targeting and intravenous busulfan is not available. A brazilian experience. Bone Marrow Transplantation. 2006 ; 37 S113.[citado 2024 maio 21 ] - Fatal evans syndrome complications allogeneic bone marrow transplantation: a case report
- Haemopoietic growth factors: a randomized, multicenter study of G-CSF starting on day +1 vs day +5 alfter autologous peripheral blood progenitor cell transplantation
- Ovarian recovery after stem cell transplantation
- The role of hematopoietic stem cell transplantation for type 1 diabetes mellitus
- Psicose aguda em enfermaria de isolamento protetor: relato de um caso
- Intra-arterial steroid therapy for steroid refractory graft-versus-host disease
- Outcome predictors of 84 patients with hemetologic malignancies and fusarium infection
- Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysi
- Beneficial effect of intravenous lidocaine in cutaneous chronic graftversus-host disease secondary to donor lymphocyte infusion
- Transplante de céluas-tronco hematopoéticas (TCTH) em doenças falciformes
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas